Depuy Spine And Advanced Technologies And Regenerative Medicine, Llc, Begin Testing Genetically Engineered Human Protein For Degenerative Disc Disease
DePuy Spine, Inc., in collaboration with Advanced Technologies and Regenerative Medicine, LLC, announced today it has begun testing of a genetically engineered human protein in patients with moderate to severe low back pain. The first in a series of clinical studies evaluating the safety and effectiveness of the protein, intradiscal rhGDF-5 (recombinant human growth and differentiation factor-5), began at Texas Back Institute in Plano, Texas.
More: continued here
Filed under: Neurology / Neuroscience on April 3rd, 2009
You must be logged in to post a comment.